Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Women's preferences for cancer risk management strategies in Lynch syndrome.

Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK.

Gynecol Oncol. 2019 Mar;152(3):514-521. doi: 10.1016/j.ygyno.2018.11.027.

PMID:
30876497
2.

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.

Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH.

Gynecol Oncol. 2018 Jul;150(1):79-84. doi: 10.1016/j.ygyno.2018.04.564. Epub 2018 May 4.

PMID:
29735278
3.

Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.

Yates MS, Coletta AM, Zhang Q, Schmandt RE, Medepalli M, Nebgen D, Soletsky B, Milbourne A, Levy E, Fellman B, Urbauer D, Yuan Y, Broaddus RR, Basen-Engquist K, Lu K.

Cancer Prev Res (Phila). 2018 Aug;11(8):477-490. doi: 10.1158/1940-6207.CAPR-17-0398. Epub 2018 May 1.

PMID:
29716897
4.

Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer.

Nebgen DR, Rhodes HE, Hartman C, Munsell MF, Lu KH.

Obstet Gynecol. 2016 Aug;128(2):357-63. doi: 10.1097/AOG.0000000000001529.

5.

Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.

Streff H, Profato J, Ye Y, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK.

Oncologist. 2016 Jul;21(7):869-74. doi: 10.1634/theoncologist.2015-0354. Epub 2016 Jun 15.

6.

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.

Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK.

Cancer. 2015 Jan 15;121(2):269-75. doi: 10.1002/cncr.29041. Epub 2014 Sep 15. Erratum in: Cancer. 2015 Jul 15;121(14):2474-5.

7.

Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome.

Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM.

Gynecol Oncol. 2014 Oct;135(1):85-9. doi: 10.1016/j.ygyno.2014.08.017. Epub 2014 Aug 19.

8.

The incidence, attitudes and practices of the removal of pubic hair as a body modification.

Bercaw-Pratt JL, Santos XM, Sanchez J, Ayensu-Coker L, Nebgen DR, Dietrich JE.

J Pediatr Adolesc Gynecol. 2012 Feb;25(1):12-4. doi: 10.1016/j.jpag.2011.06.015. Epub 2011 Nov 16.

PMID:
22088314
9.

Identification of the chondrogenic-inducing activity from bovine dentin (bCIA) as a low-molecular-mass amelogenin polypeptide.

Nebgen DR, Inoue H, Sabsay B, Wei K, Ho CS, Veis A.

J Dent Res. 1999 Sep;78(9):1484-94.

PMID:
10512382
10.

Changes in phenotypic gene expression in rat mandibular condylar cartilage cells during long-term culture.

Inoue H, Nebgen D, Veis A.

J Bone Miner Res. 1995 Nov;10(11):1691-7.

PMID:
8592945
11.

Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis.

DiPietro LA, Nebgen DR, Polverini PJ.

J Vasc Res. 1994 May-Jun;31(3):178-85.

PMID:
7511943
12.

Management of a mandibular fracture in a patient with cleidocranial dysplasia: report of a case and review of the literature.

Nebgen D, Wood RS, Shapiro RD.

J Oral Maxillofac Surg. 1991 Apr;49(4):405-9. No abstract available.

PMID:
2005496

Supplemental Content

Loading ...
Support Center